Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

Abstract This study was conducted to assess whether levetiracetam (LEV) affects the survival of patients with glioblastoma (GBM) treated with concurrent temozolomide (TMZ) chemotherapy. To this end, from 2004 to 2016, 322 patients with surgically resected and pathologically confirmed isocitrate dehy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tae Hoon Roh, Ju Hyung Moon, Hun Ho Park, Eui Hyun Kim, Chang-Ki Hong, Se Hoon Kim, Seok-Gu Kang, Jong Hee Chang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/c2151e0ede9f40f5bc078c0b974e815f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares